The public issue is entirely an offer-for-sale (OFS) of up to 21.7 million shares by the promoters and other shareholders to the tune of around ₹1,800 crore, said bankers. The company operates under the “Blue Jet” brand offering niche products targeted at innovator pharmaceutical companies and multinational generic pharmaceutical companies.
These 7 penny stocks rally 10-30% in a week
In the week ending May 23, the benchmark Sensex fell by approximately 0.74%. However, despite the overall market downturn, seven penny stocks posted weekly gains